| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 08/21/1996 | EP0727425A1 Adhesion receptor antagonists |
| 08/21/1996 | EP0726953A1 Human kunitz-type protease inhibitors |
| 08/21/1996 | EP0726899A1 Novel pyrazine carboxamide derivatives, their production and their use in medicaments |
| 08/21/1996 | EP0726895A1 Pseudodipeptide product having an imidazole grouping and applications |
| 08/21/1996 | EP0726771A1 Desferrioxamine oral delivery system |
| 08/21/1996 | EP0726768A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury |
| 08/21/1996 | EP0726764A1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 08/21/1996 | EP0726763A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
| 08/20/1996 | US5547944 An oligosaccharide sequence with a high degree of sulfation |
| 08/16/1996 | CA2169433A1 Adhesion receptor antagonists |
| 08/15/1996 | WO1996024609A1 Thrombin inhibitors |
| 08/15/1996 | WO1996024586A1 New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds |
| 08/15/1996 | WO1996024581A2 Derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds |
| 08/15/1996 | WO1996024384A1 Methods of inhibiting cell-cell adhesion |
| 08/15/1996 | WO1996024372A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic |
| 08/15/1996 | WO1996024344A1 USE OF RETINOIDS TO LOWER PLASMA LEVELS OF LIPOPROTEIN (a) |
| 08/15/1996 | WO1996007397A3 Delivery of solid drug compositions |
| 08/15/1996 | CA2212712A1 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic |
| 08/15/1996 | CA2212339A1 Methods of inhibiting cell-cell adhesion |
| 08/15/1996 | CA2212336A1 New pyridine and pyridazine derivatives, processes for the production thereof and pharmaceutical agents containing these compounds |
| 08/15/1996 | CA2212227A1 New pyridyl- and pyridazinyl-piperazine derivatives, processes for the production thereof and pharmaceutical agents containing these compounds |
| 08/15/1996 | CA2210989A1 Thrombin inhibitors |
| 08/15/1996 | CA2208077A1 Use or retinoids to lower plasma levels of lipoprotein (a) |
| 08/14/1996 | EP0726313A2 DNA coding for mammalian L-asparaginase |
| 08/14/1996 | EP0726311A1 Human activated protein c preparation and process for producing the same |
| 08/14/1996 | EP0726076A1 Method of stabilizing protein c or activated protein c and stabilized composition |
| 08/14/1996 | EP0726071A2 2-Phenyl-3-azoylbenzothiopenes for inhibiting cell-cell adhesion |
| 08/14/1996 | EP0725655A1 Platelet-specific chimeric immunoglobulin and methods of use therefor |
| 08/14/1996 | EP0725651A1 Hemoregulatory peptides |
| 08/14/1996 | EP0725635A1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 08/14/1996 | DE19504367A1 Neue Pyridin- bzw. Pyridazinderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New pyridine or pyridazine derivatives, to processes for their preparation and medicaments containing these compounds |
| 08/14/1996 | DE19504329A1 Neue Pyridyl- bzw. Pyridazinyl-Piperazinderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New pyridyl or pyridazinyl-piperazine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 08/14/1996 | CN1128658A Method for application of copper salicylacetate |
| 08/13/1996 | US5545727 DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin |
| 08/11/1996 | CA2169132A1 Use of hcp sh2 specific compounds to enhance erythropoiesis |
| 08/08/1996 | WO1996023888A1 NOVEL c-MPL LIGANDS |
| 08/08/1996 | WO1996023787A1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/08/1996 | WO1996023771A2 Platelet aggregation inhibitors |
| 08/08/1996 | WO1996023523A1 Novel hemostatic composition |
| 08/08/1996 | WO1996023512A1 Extracts of shark cartilage, process of production and uses thereof |
| 08/08/1996 | CA2212006A1 Novel c-mpl ligands |
| 08/08/1996 | CA2210746A1 Platelet aggregation inhibitors |
| 08/07/1996 | EP0724647A1 Nucleic acid ligands and improved methods for producing the same |
| 08/07/1996 | EP0724632A1 Stem cell proliferation factor |
| 08/07/1996 | EP0724436A1 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces |
| 08/07/1996 | EP0576617B1 Composition and method containing optically pure (s) metoprolol |
| 08/07/1996 | CN1128262A Substituted biphenyl isoxazole sulfonamides |
| 08/07/1996 | CN1128168A The use of vWF-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy |
| 08/07/1996 | CN1032471C Preparation for stable hemoglobin |
| 08/06/1996 | CA2026783C Use of il-7 in providing medications for stimulation of platelet production |
| 08/01/1996 | WO1996023068A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 07/31/1996 | EP0723974A1 Derivatives of mercaptoalkanoyldipeptides, their preparation and pharmaceutical compositions containing them |
| 07/31/1996 | EP0723457A1 Transferrin compositions to alleviate the side effects of cytotoxic drugs |
| 07/31/1996 | EP0723398A1 Superoxide dismutase and mimetics thereof |
| 07/31/1996 | EP0469074B1 Cysteine added variants il-3 and chemical modifications thereof |
| 07/31/1996 | CN1128022A Nipecotic acid derivatives as antithrombic compounds |
| 07/31/1996 | CN1127639A Method for preparing hemostatic and its preparation |
| 07/30/1996 | US5541343 Cyclic imino derivatives and pharmaceutical compositions containing them |
| 07/30/1996 | US5541198 Antisticking agents for platelets |
| 07/30/1996 | US5541183 Ginkgolide derivatives |
| 07/30/1996 | US5541161 Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin |
| 07/30/1996 | US5541158 Administering erythropoietin and iron |
| 07/30/1996 | US5540842 Method of producing an artificial kidney perfusion component for bicarbonate dialysis and the artificial kidney perfusion component |
| 07/25/1996 | WO1996022306A1 Novel peptide |
| 07/25/1996 | WO1996022295A1 Tricyclic benzazepine vasopressin antagonists |
| 07/25/1996 | WO1996022293A1 Tricyclic benzazepine vasopressin antagonists |
| 07/25/1996 | WO1996022288A1 GLYCOPROTEIN IIb/IIIa ANTAGONISTS |
| 07/25/1996 | WO1996022107A1 Dried blood factor composition comprising trehalose |
| 07/25/1996 | WO1996012021A3 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 07/25/1996 | CA2210682A1 Glycoprotein iib/iiia antagonists |
| 07/25/1996 | CA2210632A1 Tricyclic benzazepine vasopressin antagonists |
| 07/24/1996 | EP0722944A1 2-9-Disubstituted Purin-6-ones |
| 07/24/1996 | EP0722943A1 9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 07/24/1996 | EP0722937A1 2,8-Disubstituted quinazolinone |
| 07/24/1996 | EP0722460A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 07/24/1996 | EP0722459A1 Hemoregulatory penta- or hexapeptides |
| 07/24/1996 | EP0722328A1 Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta |
| 07/24/1996 | EP0665850A4 Fractionation of polyalkylene oxide-conjugated hemoglobin solutions. |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/24/1996 | CN1127508A Fused benzazepine derivative and pharmaceutical composition containing the same |
| 07/24/1996 | CN1127476A Plasma-like solution |
| 07/24/1996 | CA2167763A1 Mercaptoalkyldipeptide derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 07/23/1996 | US5539126 Method for preparing homochiral maleimide intermediates, via silylation techniques |
| 07/23/1996 | US5539104 1,4 Diazocines as fibrinogen antagonists |
| 07/23/1996 | US5538946 Hirudin derivatives with delayed action |
| 07/23/1996 | CA1338475C Stereospecific process for the preparation of furo ¬3,4-c| pyridine enantiomers and compounds thus obtained |
| 07/20/1996 | CA2167353A1 2,9-disubstituted purin-6-ones |
| 07/20/1996 | CA2167349A1 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 07/20/1996 | CA2167345A1 2,8-disubstituted quinazolinones |
| 07/18/1996 | WO1996021644A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/18/1996 | WO1996021452A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | WO1996008569A3 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/18/1996 | WO1995034669A3 Retroviral gene therapy vectors and therapeutic methods based thereon |
| 07/18/1996 | CA2209938A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine |
| 07/18/1996 | CA2209936A1 Indole derivatives useful in the treatment of osteoporosis |
| 07/17/1996 | EP0721955A2 Diadenosine tetraphosphate tetrasodium salt dodecahydrate crystals |
| 07/17/1996 | EP0721783A1 Preventive and remedy for diseases caused by fibrinoid or thrombus formation in the lung and model animal for said diseases |
| 07/17/1996 | EP0721344A1 Methods for stimulating interleukin-6 synthesis and inducing thrombocytopoiesis using oncostatin m |
| 07/17/1996 | EP0496866B1 Hemoglobin-oligomer based composition and method to make same |
| 07/17/1996 | CN1126759A Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide |